• Alan A. Aderem, PhD
  Professor and Director, Institute for Systems Biology
  
  

• W. Ripley Ballou, PhD
  Deputy Director for Vaccines, Infectious Diseases Division, Bill & Melinda Gates Foundation
  

• Michel De Wilde, PhD
  Executive Vice President, Research and Development, Sanofi Pasteur

• Peter C. Doherty, PhD
  Michael F. Tamer Chair, Department of Immunology, St. Jude Children's Research Hospital; Laureate Professor, Department of Microbiology and Immunology, The University of Melbourne
  
  

• José Esparza, MD, PhD
  Senior Advisor, HIV Vaccines, Bill & Melinda Gates Foundation
  

• Phillip L. Gomez III, PhD, MBA
  Principal, PRTM Management Consultants

• Harry B. Greenberg, MD
  Senior Associate Dean of Research, Joseph D. Grant Professor of Medicine and Microbiology and Immunology, School of Medicine, Stanford University
  
  
• Nancy Logan Haigwood, PhD
  Director, Oregon National Primate Research Center; Professor of Pathology, School of Public Health and Community Medicine; Professor of Microbiology, School of Medicine, Seattle Biomedical Research Institute; Member, Viral Vaccines Program, Seattle Biomedical Research Institute
  
  
• Marie-Paule Kieny, PhD (Ex-officio)
  Director, Initiative for Vaccine Research, World Health Organization
  
  

• Reinhard Kurth, MD (Chair, ex-officio)
  President Emeritus, Robert Koch Institute

• Lynn Morris, DPhil
  Head of AIDS Research Unit, National Institute for Communicable Diseases

• Thomas P. Monath, MD
  Partner, Kleiner Perkins Caufield and Byers,

  Pandemic and Defense Fund

• Marian R. Neutra, PhD
  Professor of Pediatrics, Harvard Medical School and Children's Hospital of Boston
  
  

• Stanley Plotkin, MD
  Executive Advisor to the CEO, Sanofi Pasteur

• Thomas Richie, MD, PhD
  Captain, Medical Corps, U.S. Navy; Director, Malaria Program, Navy Component, U.S. Military Malaria Vaccine Program, Naval Medical Research Center/Walter Reed Army Institute of Research

• Alan Shaw, PhD
  Chairman and Chief Scientific Officer, VaxInnate Corp.
  
  

• Robin Shattock, PhD
  Professor of Molecular Infection, Center for Infection, Department of Cellular and Molecular Medicine, St. George's, University of London

Policy Advisory Committee:

• David Kihumuro Apuuli, MD
  Director-General, Uganda AIDS Commission

• Emma Back, MA
  Independent Consultant
  
  
• Ciro de Quadros, MD, MPH
  Director, International Programs, Albert B. Sabin Vaccine Institute; Former Director, Vaccines and Immunization, Pan American Health Organization

• Christopher J. Elias, MD, MPH
  President, PATH

• José Esparza, MD, PhD
  Senior Advisor, HIV Vaccines, Bill and Melinda Gates Foundation Global Health Program

• Michel Gréco, MS, MBA
  Former President, Chief Operating Officer and Deputy Chief Executive Officer, Aventis Pasteur; Former President and Chief Operating Officer, Pasteur Mérieux MSD

• Purnima Mane, PhD, MA, MPhil
  Deputy Executive Director, United Nations Population Fund
  
  
• Cristina de Albuquerque Possas
  Head of the Research and Development Unit, National STD-AIDS Program, Brazilian Ministry of Health
  


• Jeffrey Sturchio, PhD

  President & CEO, Global Health Council

• Mark A. Wainberg, PhD
  Professor and Director, McGill University AIDS Centre

• Mitchell Warren (Observer)
  Executive Director, AIDS Vaccine Advocacy Coalition

• Alan Whiteside, MA, D Econ
  Director, Health Economics and HIV/AIDS Research Division, University of KwaZulu-Natal